Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...
Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
The State Cabinet here on Tuesday approved Industrial Promotion Policy 2025 with the aim of transforming Madhya Pradesh into a developed and prosperous state. The policy includes 10 sector-specific ...
Unveiling the truth about healthcare profits: 95% of net income goes to shareholders, not improving healthcare services or ...
Everyday painkillers, antibiotics, cancer medications, blood thinners and more are just some of the drugs that the U.S.
Tariffs declared by the US that had been set to start for two nations overnight would push costs up for many healthcare items.
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the ...
Majority of leaders in life sciences -- pharmaceutical and medical technology companies -- and high-tech companies like ...
Similarly, when medical device manufacturers require automated assembly systems for complex applications, they, too, turn to ...
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback